McKesson Corporation $MCK Shares Newly Purchased by Neumann Capital Management LLC

Neumann Capital Management LLC purchased a new stake in shares of McKesson Corporation (NYSE:MCK) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,160 shares of the company’s stock, valued at approximately $1,844,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Rosenberg Matthew Hamilton grew its stake in McKesson by 2.8% during the third quarter. Rosenberg Matthew Hamilton now owns 406 shares of the company’s stock worth $347,000 after buying an additional 11 shares during the last quarter. Anchyra Partners LLC increased its holdings in shares of McKesson by 1.0% during the first quarter. Anchyra Partners LLC now owns 1,174 shares of the company’s stock worth $1,016,000 after buying an additional 12 shares in the last quarter. SJS Investment Consulting Inc. raised its stake in shares of McKesson by 7.5% in the first quarter. SJS Investment Consulting Inc. now owns 172 shares of the company’s stock valued at $149,000 after acquiring an additional 12 shares during the last quarter. SMART Wealth LLC raised its stake in shares of McKesson by 3.4% in the first quarter. SMART Wealth LLC now owns 366 shares of the company’s stock valued at $317,000 after acquiring an additional 12 shares during the last quarter. Finally, Stephens Inc. AR raised its stake in shares of McKesson by 0.8% in the first quarter. Stephens Inc. AR now owns 1,581 shares of the company’s stock valued at $1,368,000 after acquiring an additional 12 shares during the last quarter. 85.07% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently commented on MCK. Argus boosted their target price on McKesson from $850.00 to $970.00 and gave the stock a “buy” rating in a report on Thursday, September 3rd. Morgan Stanley set a $977.00 price target on McKesson in a report on Tuesday, October 6th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $845.00 price target on shares of McKesson in a report on Monday, September 14th. Citigroup lifted their price objective on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Finally, Evercore reissued an “outperform” rating and issued a $950.00 price objective (down from $1,000.00) on shares of McKesson in a research note on Thursday, August 6th. Fifteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, McKesson has an average rating of “Moderate Buy” and a consensus target price of $983.29.

Insider Buying and Selling

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the company’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total transaction of $98,950.95. Following the transaction, the chief accounting officer owned 521 shares of the company’s stock, valued at approximately $464,445.45. This represents a 17.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of the company’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $892.33, for a total value of $268,591.33. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.06% of the company’s stock.

McKesson Stock Up 2.1%

Shares of NYSE:MCK opened at $997.40 on Friday. The firm has a market cap of $116.29 billion, a P/E ratio of 26.69, a P/E/G ratio of 1.94 and a beta of 0.30. McKesson Corporation has a 12 month low of $723.68 and a 12 month high of $1,003.21. The company’s 50-day moving average price is $894.99 and its two-hundred day moving average price is $836.32.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, topping analysts’ consensus estimates of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The company had revenue of $105.38 billion during the quarter, compared to the consensus estimate of $103.88 billion. During the same period in the previous year, the firm posted $8.26 earnings per share. The company’s revenue was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, equities analysts predict that McKesson Corporation will post 44.71 earnings per share for the current fiscal year.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Tuesday, September 1st were issued a $0.94 dividend. This is an increase from McKesson’s previous quarterly dividend of $0.82. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Tuesday, September 1st. McKesson’s dividend payout ratio (DPR) is 10.06%.

Key McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Leerink raised its price target to $1,070, implying additional upside from recent levels and reinforcing the bullish analyst outlook. Leerink lifts target for McKesson stock to USD 1,070
• Positive Sentiment: Jim Cramer called McKesson a health-care “winner,” adding favorable high-profile commentary as the stock continues to outperform the broader market. Jim Cramer: This Health Care Stock Is A Winner
• Positive Sentiment: McKesson approached $1,000 after setting a fresh 52-week high near $998.64, signaling strong momentum and sustained demand for the shares. McKesson Approaches $1,000 After Setting a New 52-Week High
• Positive Sentiment: Separate coverage reported an all-time high around $1,000.97, while another report highlighted a $1.4 billion McKesson commitment, adding to the company’s favorable news flow. McKesson stock hits all-time high
• Neutral Sentiment: The rally follows McKesson’s latest quarterly results, which exceeded EPS and revenue expectations and showed 7.7% year-over-year revenue growth. However, the stock is near its 12-month high, which may increase sensitivity to profit-taking.

About McKesson

McKesson Corporation (NYSE:MCK) is a healthcare services and information technology company that distributes pharmaceuticals, specialty drugs, medical supplies and other healthcare products. The company serves pharmacies, hospitals, health systems, physician practices, biopharma manufacturers and other healthcare providers, helping move products from manufacturers to patients and care settings.

McKesson’s principal operations include pharmaceutical distribution, medical-surgical supply distribution and technology-enabled services for pharmacies and providers.